Evidence map›Paper›PMID 39559353›Full record

ReviewFrontiers in immunology2024

Hypoxia-adenosinergic regulation of B cell responses.

Layne Pruitt, Robert K Abbott

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Layne PruittDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, United States.
Robert K AbbottDepartment of Pathology, University of Texas Medical Branch, Galveston, TX, United States.

Funding

Revealing the Biophysics of the Germinal Center MicroenvironmentDP2AI154410 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Robert Koehler Abbott · 2022 to 2026
$2.4M
Mapping the germinal center and memory B cell landscape to complex antigensR00AI145762 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ABBOTT, ROBERT KOEHLER · 2021 to 2022
$503k
NIAID NIH HHS DP2 AI154410NIAID NIH HHS R00 AI145762
6 · The paper itself

Abstract

Hypoxic microenvironments induce widespread metabolic changes that have been shown to be critical in regulating innate and adaptive immune responses. Hypoxia-induced changes include the generation of extracellular adenosine followed by subsequent signaling through adenosine receptors on immune cells. This evolutionarily conserved "hypoxia-adenosinergic" pathway of hypoxia → extracellular adenosine → adenosine receptor signaling has been shown to be critical in limiting and redirecting T cell responses including in tumor microenvironments and the gut mucosa. However, the question of whether hypoxic microenvironments are involved in the development of B cell responses has remained unexplored until recently. The discovery that germinal centers (GC), the anatomic site in which B cells undergo secondary diversification and affinity maturation, develop a hypoxic microenvironment has sparked new interest in how this evolutionarily conserved pathway affects antibody responses. In this review we will summarize what is known about hypoxia-adenosinergic microenvironments in lymphocyte development and ongoing immune responses. Specific focus will be placed on new developments regarding the role of the hypoxia-adenosinergic pathway in regulating GC development and humoral immunity.

Indexed as

AdenosineB-LymphocytesHypoxiaSignal TransductionAnimalsGerminal CenterHumansImmunity, HumoralReceptors, Purinergic P1AdenosineReceptors, Purinergic P1adenosineantibodyB cellhypoxiametabolismvaccine

Identifiers

PMID39559353
PMCPMC11570280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.